Impax Asset Management Group
ZBH icon

Impax Asset Management Group’s Zimmer Biomet ZBH Stock Holding History

Impax Asset Management Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,601
Closed -$560K – 369
2023
Q4 		$560K Buy
4,601
+297
+7% +$33.1K ﹤0.01% 336
2023
Q3 		$483K Sell
4,304
-400
-9% -$50.8K ﹤0.01% 340
2023
Q2 		$685K Sell
4,704
-502
-10% -$68.2K ﹤0.01% 309
2023
Q1 		$673K Buy
5,206
+381
+8% +$47.8K ﹤0.01% 302
2022
Q4 		$615K Sell
4,825
-2,344
-33% -$272K ﹤0.01% 301
2022
Q3 		$750K Sell
7,169
-156
-2% -$17.1K ﹤0.01% 287
2022
Q2 		$770K Sell
7,325
-76
-1% -$9.02K ﹤0.01% 293
2022
Q1 		$947K Buy
7,401
+115
+2% +$13.9K ﹤0.01% 296
2021
Q4 		$898K Buy
+7,286
New +$954K ﹤0.01% 297

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Impax Asset Management Group's ZBH Position: Q1 2024 in Review

Impax Asset Management Group sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 4,601 shares — an estimated $560K sold.

Impax Asset Management Group first reported a position in ZBH in Q4 2021 and held it in 9 quarters. The position peaked at $947K in Q1 2022. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Impax Asset Management Group reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Impax Asset Management Group sold 4,601 Zimmer Biomet shares in Q1 2024, an estimated $560K.
  • Impax Asset Management Group first reported a position in Zimmer Biomet in Q4 2021 and held it in 9 quarters.
  • Impax Asset Management Group's Zimmer Biomet position peaked at $947K in Q1 2022.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Impax Asset Management Group's 13F filing for Q1 2024, filed 30 Apr 2024.